- NCIt
- C8101
Loading cancer entity…
Loading cancer entity…
Clinical trials
1,164 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00004189 | Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00004229 | Endostatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00004242 |
| Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors |
| completed |
| Phase 1 |
| 30 |
| National Cancer Institute (NCI)NIH |
| 1 |
| Feb 11, 2013 |
| clinicaltrials |
| NCT00006221 | BMS-247550 in Treating Patients With Advanced Cancers | completed | Phase 1 | 54 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00003249 | Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced Cancers | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00004241 | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00025415 | Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00027898 | Bortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 27 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00030615 | Decitabine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00287937 | Vorinostat, Paclitaxel, and Carboplatin in Treating Patients With Advanced or Refractory Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00002759 | Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma | completed | Phase 1 | 3 | National Cancer Institute (NCI)NIH | 1 | Feb 5, 2013 | clinicaltrials |
| NCT00002909 | Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Feb 5, 2013 | clinicaltrials |
| NCT00003451 | Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00004079 | Sarcosinamide Nitrosourea in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 46 | National Cancer Institute (NCI)NIH | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00005604 | Interleukin-12 Plus Interleukin-2 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 25 | National Cancer Institute (NCI)NIH | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00006242 | BMS-214662 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00068484 | A Dose Finding Phase I Trial of the Combination of Topotecan and PS-341, a Novel Proteasome Inhibitor, in Advanced Malignancies | completed | Phase 1 | 25 | National Cancer Institute (NCI)NIH | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00006000 | SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00238225 | Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 15 | Roswell Park Cancer InstituteOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00275093 | Temsirolimus in Treating Patients With Metastatic Solid Tumor or Lymphoma That Cannot Be Removed By Surgery Who Have Different Levels of Liver Function | completed | Phase 1 | 130 | National Cancer Institute (NCI)NIH | 1 | Jan 30, 2013 | clinicaltrials |
| NCT00244868 | Computer-Based Survey and Communication Aid in Improving Physician-Patient Communication and Treatment Decision Making in Patients With Metastatic Cancer | completed | Phase 3 | 720 | Fox Chase Cancer CenterOTHER | 1 | Jan 29, 2013 | clinicaltrials |
| NCT00022113 | EMD 121974 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 35 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00022529 | BMS-214662 Plus Trastuzumab in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 28 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00039390 | Gefitinib and Capecitabine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00079352 | Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00087217 | 17-N-Allylamino-17-Demethoxygeldanamycin and Paclitaxel in Treating Patients With Metastatic or Unresectable Solid Tumor | completed | Phase 1 | 35 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00089271 | 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00003970 | Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00042809 | Erlotinib, Trastuzumab, and Paclitaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00062127 | Irinotecan and Thalidomide in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 35 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00074022 | GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors | completed | Phase 1 / Phase 2 | 48 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00077155 | Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | 45 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00078962 | GTI-2040 and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00098891 | MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00005973 | BMS-214662 in Treating Patients With Solid Tumors | completed | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00024206 | SU6668 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 12 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00005805 | St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer | completed | Phase 3 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 18, 2013 | clinicaltrials |
| NCT00084786 | Gefitinib and Docetaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 17, 2013 | clinicaltrials |
| NCT00003282 | EF5 in Treating Patients With Solid Tumors | completed | Phase 1 | 50 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00028587 | PS-341 and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 96 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00028821 | 2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00030498 | Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction | completed | Phase 1 | 75 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00017238 | KRN5500 in Treating Patients With Solid Tumors | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Jan 11, 2013 | clinicaltrials |
| NCT00026169 | Imatinib Mesylate in Treating Patients With Advanced Cancer and Kidney Failure | completed | Phase 1 | 69 | National Cancer Institute (NCI)NIH | 1 | Jan 10, 2013 | clinicaltrials |
| NCT00891072 | Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery | completed | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | Jan 10, 2013 | clinicaltrials |
| NCT00047034 | E7389 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 31 | National Cancer Institute (NCI)NIH | 1 | Jan 7, 2013 | clinicaltrials |
| NCT00118170 | Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney Function | completed | Phase 1 | 150 | National Cancer Institute (NCI)NIH | 1 | Jan 7, 2013 | clinicaltrials |
| NCT00124605 | Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jan 7, 2013 | clinicaltrials |
| NCT00849550 | Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors.(COBRA) | completed | Phase 1 | 32 | Herbert HurwitzOTHER | 1 | Dec 24, 2012 | clinicaltrials |
| NCT00098969 | UMCC 2003-064 Resveratrol in Preventing Cancer in Healthy Participants(IRB 2004-535) | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 2 | Dec 17, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Feb 11, 2013source: clinicaltrials